Jieru Li
Lanzhou, 730030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Redox-responsive metal-organic framework nanocapsules enhance tumor chemo-immunotherapy by modulating tumor metabolic reprogramming.
Journal: Materials today. Bio
Published: December 01, 2024
A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic cancer therapy efficiency.
Journal: Materials today. Bio
Published: November 07, 2024
Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 30, 2024
Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism.
Journal: Colloids and surfaces. B, Biointerfaces
Published: June 25, 2024
The Peptide DHα-(4-pentenyl)-ANPQIR-NH2 Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 24, 2023
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis.
Journal: Acta pharmaceutica Sinica. B
Published: April 24, 2022
DR7dA, a Novel Antioxidant Peptide Analog, Demonstrates Antifibrotic Activity in Pulmonary Fibrosis In Vivo and In Vitro.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 21, 2021
Peptide DR8 analogs alleviate pulmonary fibrosis via suppressing TGF-β1 mediated epithelial-mesenchymal transition and ERK1/2 pathway in vivo and in vitro.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026